{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T05:55:41Z","timestamp":1719467741744},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057789","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T08:13:13Z","timestamp":1362211993000},"page":"e57789","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transmission Patterns of HIV-Subtypes A\/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy"],"prefix":"10.1371","volume":"8","author":[{"given":"Boaz","family":"Avidor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Chalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaris","family":"Riesenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Shahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Elbirt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zev","family":"Sthoeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Maayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Olshtain-Pops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Averbuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Chowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery","family":"Istomin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Anis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzchak","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehava","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg079","article-title":"Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance","volume":"51","author":"S Spira","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/v2112493","article-title":"Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs","volume":"2","author":"MA Wainberg","year":"2010","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/420790","article-title":"Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates","volume":"190","author":"DR Bangsberg","year":"2004","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/QAD.0b013e32833d207d","article-title":"Global HIV surveillance among MSM: is risk behavior seriously underestimated","volume":"24","author":"L Bengtsson","year":"2010","journal-title":"AIDS"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/cid\/cir244","article-title":"Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases","volume":"52","author":"I Levy","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1468-1293.2011.00960.x","article-title":"Emergence of an HIV-1 cluster harbouring the major protease L90M mutation among treatment-naive patients in Tel Aviv, Israel","volume":"13","author":"D Turner","year":"2011","journal-title":"HIV Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/bmj.294.6579.1083","article-title":"ABC of AIDS. Development of the epidemic","volume":"294","author":"MW Adler","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/08892220260190380","article-title":"Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union","volume":"18","author":"AA Nabatov","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref9","first-page":"11276","article-title":"Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: selection of the V77I variant and its rapid spread in injecting drug user populations. J. Virol","volume":"78","author":"NI Roudinskii","year":"2004"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/aid.2006.22.796","article-title":"Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan","volume":"22","author":"MD Saad","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref11","unstructured":"UNAIDS. 2010 Global Report (2011) Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/documents\/20101123_GlobalReport\/\" xlink:type=\"simple\">http:\/\/www.unaids.org\/documents\/20101123_GlobalReport\/<\/ext-link>."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/QAD.0b013e328342ff93","article-title":"Global trends in molecular epidemiology of HIV-1 during 2000\u20132007","volume":"25","author":"J Hemelaar","year":"2011","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"BM Mathers","year":"2008","journal-title":"Lancet"},{"key":"ref14","first-page":"2","article-title":"The epidemiology of adult AIDS and HIV infection in Israel","volume":"29","author":"PE Slater","year":"1993","journal-title":"Isr J Med Sci"},{"key":"ref15","first-page":"215","article-title":"How many HIV infections are there in Israel? Reconstructing HIV incidence from AIDS case reporting","volume":"23","author":"EH Kaplan","year":"1995","journal-title":"Public Health Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/095646240401501011","article-title":"Epidemiology of adult and adolescent HIV infection in Israel: a country of immigration","volume":"15","author":"D Chemtob","year":"2004","journal-title":"Int J STD AIDS"},{"key":"ref17","unstructured":"Mor Z, Pinsker G (2011) HIV\/AIDS in Israel, Epidemiological Periodic Report 1981\u20132010. Public Health Services, Department of Tuberculosis &amp; AIDS, MOH, Israel. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.health.gov.il\/TBAIDS\" xlink:type=\"simple\">www.health.gov.il\/TBAIDS<\/ext-link>."},{"key":"ref18","unstructured":"Central Bureau of Statistics Jerusalem, the State of Israel (2010) Statistical abstract of Israel, Jerusalem. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www1.cbs.gov.il\/\" xlink:type=\"simple\">http:\/\/www1.cbs.gov.il\/<\/ext-link>."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1097\/QAD.0b013e3283121c90","article-title":"Transmission networks of drug resistance acquired in primary\/early stage HIV infection","volume":"22","author":"BG Brenner","year":"2008","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0040343","article-title":"Assessment of recent HIV-1 infection by a line immunoassay for HIV-1\/2 confirmation","volume":"4","author":"J Schupbach","year":"2007","journal-title":"PLoS Med"},{"key":"ref21","first-page":"1453","article-title":"Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B. AIDS","volume":"15","author":"Z Grossman","year":"2001"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/nar\/29.1.296","article-title":"Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs","volume":"29","author":"R Kantor","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"SY Rhee","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.aids.0000216363.36786.2b","article-title":"HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes","volume":"20","author":"SY Rhee","year":"2006","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: update","volume":"4","author":"DE Bennett","year":"2009","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"K Tamura","year":"2009","journal-title":"Mol Biol Evol"},{"key":"ref27","unstructured":"Rambaut A. FigTree v1.3.1. (2009) Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/tree.bio.ed.ac.uk\/software\/figtree\/\" xlink:type=\"simple\">http:\/\/tree.bio.ed.ac.uk\/software\/figtree\/<\/ext-link>."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Drummond AJ, Suchard MA, Xie D, Rambaut A (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol.","DOI":"10.1093\/molbev\/mss075"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/JVI.76.4.1697-1706.2002","article-title":"Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity","volume":"76","author":"KR Collins","year":"2002","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e3282f29478","article-title":"Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase","volume":"22","author":"M Kearney","year":"2008","journal-title":"AIDS"},{"key":"ref31","first-page":"A172","article-title":"Identification of HIV Transmission Networks in Israel","volume":"17","author":"Z Grossman","year":"2012","journal-title":"Antiviral Therapy"},{"key":"ref32","first-page":"634","article-title":"[\u201cInjecting clean or being clean?\u201d The international and Israeli experiences of Syringe Exchange Programs among injecting drug users]","volume":"147","author":"D Chemtob","year":"2008","journal-title":"Harefuah"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1371\/journal.pmed.0020112","article-title":"Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration","volume":"2","author":"R Kantor","year":"2005","journal-title":"PLoS Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00126334-200307010-00007","article-title":"Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection","volume":"33","author":"K Ariyoshi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jac\/dkr582","article-title":"The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors","volume":"67","author":"JL Martinez-Cajas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3851\/IMP1412","article-title":"The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999\u20132005","volume":"14","author":"AM Audelin","year":"2009","journal-title":"Antivir Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/135965350601100506","article-title":"Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997\u20132004","volume":"11","author":"N Lohse","year":"2006","journal-title":"Antivir Ther"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-4690-5-12","article-title":"The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001\u20132006) in Portugal","volume":"5","author":"J Vercauteren","year":"2008","journal-title":"Retrovirology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/135965350901400308","article-title":"Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy","volume":"14","author":"S Di Giambenedetto","year":"2009","journal-title":"Antivir Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e12718","DOI":"10.1371\/journal.pone.0012718","article-title":"Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort","volume":"5","author":"B Bartmeyer","year":"2010","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e10952","DOI":"10.1371\/journal.pone.0010952","article-title":"Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study","volume":"5","author":"M Lataillade","year":"2010","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1128\/AAC.48.6.2159-2165.2004","article-title":"Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir","volume":"48","author":"Z Grossman","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1073\/pnas.0609642104","article-title":"Mutations in the connection domain of HIV-1 reverse transcriptase increase 3\u2032-azido-3\u2032-deoxythymidine resistance","volume":"104","author":"GN Nikolenko","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/QAI.0b013e3181e6763f","article-title":"Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens","volume":"55","author":"V Svicher","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"JE Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e3281ac229b","article-title":"Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase","volume":"21","author":"UM Parikh","year":"2007","journal-title":"AIDS"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","article-title":"Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs","volume":"14","author":"L Shen","year":"2008","journal-title":"Nat Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1073\/pnas.1018360108","article-title":"Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance. Proc. Natl. aca. Sci","volume":"108","author":"MES Sampah","year":"2011","journal-title":"USA"},{"key":"ref49","first-page":"1378","article-title":"Antiretroviral dynamics determines HIV evolution and predicts therapy outcome. Nat. Med","volume":"18","author":"DIS Rosenbloom","year":"2012"},{"key":"ref50","first-page":"9094","article-title":"Gag determinants of fitness and drug susceptibility in protease inhibitor\u2013resistant human immunodeficiency virus type 1. J. Virol","volume":"83","author":"CM Parry","year":"2009"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Dam E, Quercia R, Glass B, Descamps D, Launay O, <etal>et al<\/etal>. (2009) Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss. PLoS Pathog. 5, e1000345.","DOI":"10.1371\/journal.ppat.1000345"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/QAD.0b013e3283398216","article-title":"Full length HIV-1 gag determines protease inhibitor susceptibility within in vitro assays","volume":"24","author":"RK Gupta","year":"2010","journal-title":"AIDS"},{"key":"ref53","first-page":"1099","article-title":"Ongoing HIV dissemination during HAART. Nat Med","volume":"5","author":"Z Grossman","year":"1999"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00002030-200201250-00009","article-title":"Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia","volume":"16","author":"SG Deeks","year":"2002","journal-title":"AIDS 25"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMra1004180","article-title":"Development of antiretroviral drug resistance","volume":"365","author":"MA Wainberg","year":"2011","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"AM Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"T de Oliveira","year":"2005","journal-title":"Bioinformatics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T20:04:45Z","timestamp":1715025885000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057789"}},"subtitle":[],"editor":[{"given":"Mark","family":"Wainberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057789","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}